188 related articles for article (PubMed ID: 8583101)
1. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
Ardizzone S; Petrillo M; Molteni P; Desideri S; Bianchi Porro G
J Clin Gastroenterol; 1995 Dec; 21(4):287-9. PubMed ID: 8583101
[TBL] [Abstract][Full Text] [Related]
2. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
3. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Wang Y; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
[TBL] [Abstract][Full Text] [Related]
4. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000544. PubMed ID: 32856298
[TBL] [Abstract][Full Text] [Related]
5. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
6. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
Ann Intern Med; 1996 Jan; 124(2):204-11. PubMed ID: 8533995
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
Rutgeerts P
Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
Dew MJ; Hughes P; Harries AD; Williams G; Evans BK; Rhodes J
Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1012. PubMed ID: 6127137
[No Abstract] [Full Text] [Related]
9. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Macdonald JK
Cochrane Database Syst Rev; 2006 Apr; (2):CD000544. PubMed ID: 16625537
[TBL] [Abstract][Full Text] [Related]
10. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Roth D; Beck P; May G; Makiyama K
Cochrane Database Syst Rev; 2002; (4):CD000544. PubMed ID: 12519547
[TBL] [Abstract][Full Text] [Related]
11. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
Kam L; Cohen H; Dooley C; Rubin P; Orchard J
Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
[TBL] [Abstract][Full Text] [Related]
12. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
[TBL] [Abstract][Full Text] [Related]
13. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Andreoli A; Spinella S; Levenstein S; Prantera C
Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
[TBL] [Abstract][Full Text] [Related]
14. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
Ewe K; Becker K; Ueberschaer B
Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
[TBL] [Abstract][Full Text] [Related]
15. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
d'Albasio G; Trallori G; Ghetti A; Milla M; Nucci A; Pacini F; Morettini A
Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284
[TBL] [Abstract][Full Text] [Related]
16. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
[No Abstract] [Full Text] [Related]
17. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
18. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
Kruis W; Schreiber S; Theuer D; Brandes JW; Schütz E; Howaldt S; Krakamp B; Hämling J; Mönnikes H; Koop I; Stolte M; Pallant D; Ewald U
Gut; 2001 Dec; 49(6):783-9. PubMed ID: 11709512
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
[TBL] [Abstract][Full Text] [Related]
20. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Rachmilewitz D
BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]